Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The NEK family of serine/threonine kinases as a biomarker for cancer. | Clin Exp Med | 2023 | 35037094 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
| Patterns of Ciliation and Ciliary Signaling in Cancer. | Rev Physiol Biochem Pharmacol | 2023 | 32761455 | PubTator, text mining | PubMed |
| The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. | Front Oncol | 2022 | 36793341 | PubTator, text mining | PubMed |
| Identification and comprehensive analysis of circRNA-miRNA-mRNA regulatory networks in osteoarthritis. | Front Immunol | 2022 | 36700234 | PubTator, text mining | PubMed |
| Genetic Predisposition to Hepatocellular Carcinoma. | Metabolites | 2022 | 36676960 | PubTator, text mining | PubMed |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. | Genes (Basel) | 2022 | 36672847 | PubTator, text mining | PubMed |
| Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification. | Ann Transl Med | 2022 | 36660701 | PubTator, text mining | PubMed |
| Analysis of rod-cone dystrophy genes reveals unique mutational patterns. | BMJ Open Sci | 2022 | 36618607 | PubTator, text mining | PubMed |
| Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2022 | 36614089 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36612193 | PubTator, text mining | PubMed |
| The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis. | Cancers (Basel) | 2022 | 36612111 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Contribution of integrin adhesion to cytokinetic abscission and genomic integrity. | Front Cell Dev Biol | 2022 | 36578785 | PubTator, text mining | PubMed |
| Particle Therapy: Clinical Applications and Biological Effects. | Life (Basel) | 2022 | 36556436 | PubTator, text mining | PubMed |
| Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis. | Genes (Basel) | 2022 | 36553600 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference. | Cancers (Basel) | 2022 | 36551698 | PubTator, text mining | PubMed |
| Identification of biological pathways and processes regulated by NEK5 in breast epithelial cells via an integrated proteomic approach. | Cell Commun Signal | 2022 | 36550548 | PubTator, text mining | PubMed |
A holistic comparison of flavor signature and chemical profile in different harvesting periods of Chrysanthemum morifolium Ramat. based on metabolomics combined with bioinformatics and molecular docking strategy. | RSC Adv | 2022 | 36540235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=17